Oramed Pharmaceuticals Inc. Stock Deutsche Boerse AG
Equities
OJU1
US68403P2039
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.179 EUR | +0.09% | +7.60% | +4.21% |
Sales 2024 * | 1.3M 1.22M | Sales 2025 * | - | Capitalization | 99.68M 93.22M |
---|---|---|---|---|---|
Net income 2024 * | -10M -9.35M | Net income 2025 * | - | EV / Sales 2024 * | 76.7 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-9.46
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.7% |
1 day | +0.09% | ||
1 week | +7.60% | ||
Current month | -15.61% | ||
1 month | -12.94% | ||
3 months | +5.88% | ||
6 months | +22.69% | ||
Current year | +4.21% |
Managers | Title | Age | Since |
---|---|---|---|
Miriam Kidron
FOU | Founder | 83 | 02-04-11 |
Nadav Kidron
CEO | Chief Executive Officer | 50 | 02-04-11 |
Joshua Hexter
COO | Chief Operating Officer | 53 | 13-04-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nadav Kidron
CEO | Chief Executive Officer | 50 | 02-04-11 |
Miriam Kidron
FOU | Founder | 83 | 02-04-11 |
Leonard Sank
BRD | Director/Board Member | 59 | 07-10-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.179 | +0.09% | 1,500 |
24-04-25 | 2.177 | -0.27% | 0 |
24-04-24 | 2.183 | +1.11% | 0 |
24-04-23 | 2.159 | +2.32% | 0 |
24-04-22 | 2.11 | +4.20% | 0 |
Delayed Quote Deutsche Boerse AG, April 26, 2024 at 07:39 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ORMP Stock
- OJU1 Stock